Debebe, Z., Ammosova, T., Breuer, D., Lovejoy, D. B., Kalinowski, D. S., Karla, P. K., . . . Nekhai, S. (2011). Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9. The American Society for Pharmacology and Experimental Therapeutics.
Styl cytowania ChicagoDebebe, Zufan, et al. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone And 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9. The American Society for Pharmacology and Experimental Therapeutics, 2011.
Styl cytowania MLADebebe, Zufan, et al. Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone And 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9. The American Society for Pharmacology and Experimental Therapeutics, 2011.